跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 13,363 条关于
“Kardia 12L”
全部
13,363
临床试验
11,939
药物
871
机构
47
资讯
506
5个月前
AliveCor Receives CE Mark for Portable 12-Lead ECG System with AI-Powered Cardiac Detection
2年前
Alnylam Advances Zilebesiran to Phase 3 Cardiovascular Outcomes Trial Following Positive KARDIA-3 Results
去年
Roche and Alnylam Advance Zilebesiran to Phase III Cardiovascular Outcomes Trial Following Positive KARDIA-3 Results
去年
Alnylam Advances Heart Drug Zilebesiran to Phase 3 Trial Despite Mid-Stage Statistical Miss
2年前
Single Injection of Zilebesiran Reduces Blood Pressure by Up to 12 mmHg in Phase 2 Trial
去年
Alnylam's Zilebesiran Receives MHRA Innovation Passport for Hypertension Treatment
去年
Alnylam's Zilebesiran Advances to Phase III ZENITH Trial for Hypertension Treatment
2个月前
Beyond the Pill: RNA Interference, Aldosterone Synthase Inhibition and Incretins Reshape Hypertension Drug Development
去年
ALNY Announces Preliminary 2024 Results and 2025 Outlook
去年
Alnylam Reports Strong 33% Growth, Sets Ambitious $2.25B Revenue Target for 2025
第 1 页,共 51 页
上一页
下一页